Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06003881
Status:
AVAILABLE
Last Update Posted:
2023-08-22
First Post:
2023-08-14
Brief Title:
Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| CD55-Deficient Protein-Losing Enteropathy |
Keywords: